2026 Yardena Samuels: Genetics Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Genetics	58	3289	3110	32	31	131	25249

Yardena Samuels publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Yardena Samuels sits on this spectrum.

45 publications 703+

This scientist: 131 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Yardena Samuels D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Yardena Samuels sits on this spectrum.

40 D-Index 160+

This scientist: 58 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Yardena Samuels is affiliated with the Weizmann Institute of Science in Israel and has a significant presence in the fields of biochemistry, genetics, molecular biology, medicine, immunology, and microbiology. Their research primarily spans molecular biology, immunology, oncology, radiology, nuclear medicine, imaging, and cancer research.

Their scholarly work covers multiple specialized topics, including:

Immunotherapy and Immune Responses
Vaccines and immunoinformatics approaches
Cancer Immunotherapy and Biomarkers
Monoclonal and Polyclonal Antibodies Research
CAR-T Cell Therapy Research
RNA and protein synthesis mechanisms
Melanoma and MAPK Pathways

Key recent publications by Yardena Samuels include:

"Identification of bacteria-derived HLA-bound peptides in melanoma," 2021, Nature
"Melanoma models for the next generation of therapies," 2021, Cancer Cell
"Mechanisms of immune activation and regulation: lessons from melanoma," 2022, Nature Reviews Cancer
"Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma," 2020, Nature Communications
"Anti-tumour immunity induces aberrant peptide presentation in melanoma," 2020, Nature

Their frequent coauthors include:

Ronen Levy
Yishai Levin
Michal Alon
Osnat Bartok
Polina Greenberg

Their research has been published predominantly in the following scientific venues:

Nature Cancer
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Research
Nature
Cancer Cell

Yardena Samuels' work has contributed to the understanding of immune activation, tumor immunity, and melanoma biology, highlighting molecular pathways and immune responses relevant for developing novel therapeutic strategies.

Best Publications

High frequency of mutations of the PIK3CA gene in human cancers

Yardena Samuels;Zhenghe Wang;Alberto Bardelli;Natalie Silliman

4219
Citations
Genomic Classification of Cutaneous Melanoma

Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

3009
Citations
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Paul F. Robbins;Yong Chen Lu;Mona El-Gamil;Yong F. Li

1202
Citations
Mutant PIK3CA promotes cell growth and invasion of human cancer cells

Yardena Samuels;Luis A. Diaz;Oleg Schmidt-Kittler;Jordan M. Cummins

1103
Citations
The PIK3CA gene is mutated with high frequency in human breast cancers

Kurtis E. Bachman;Pedram Argani;Yardena Samuels;Natalie Silliman

869
Citations
The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations

Chuan Hsiang Huang;Chuan Hsiang Huang;Diana Mandelker;Diana Mandelker;Oleg Schmidt-Kittler;Oleg Schmidt-Kittler;Yardena Samuels;Yardena Samuels

689
Citations
Oncogenic PI3K and its role in cancer.

Yardena Samuels;Kajsa Ericson

680
Citations
Oncogenic Mutations of PIK3CA in Human Cancers

Yardena Samuels;Victor E. Velculescu

602
Citations
Exome sequencing identifies GRIN2A as frequently mutated in melanoma

Xiaomu Wei;Vijay Walia;Jimmy C Lin;Jamie K Teer

576
Citations
Colorectal cancer: mutations in a signalling pathway.

D. Williams Parsons;Tian Li Wang;Yardena Samuels;Alberto Bardelli;Alberto Bardelli

566
Citations
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer

David A. Solomon;Taeyeon Kim;Laura A. Diaz-Martinez;Joshlean Fair

525
Citations
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Daniele Bergamaschi;Yardena Samuels;Nigel J. O'Neil;Giuseppe Trigiante

524
Citations
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas

Daniel K. Broderick;Chunhui Di;Timothy J. Parrett;Yardena R. Samuels

440
Citations
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

Yong Chen Lu;Xin Yao;Jessica S. Crystal;Yong F. Li

425
Citations
Analysis of the Tyrosine Kinome in Melanoma Reveals Recurrent Mutations in ERBB4

Todd D Prickett;Neena S Agrawal;Xiaomu Wei;Kristin E Yates

413
Citations
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

Kensuke Tateishi;Hiroaki Wakimoto;A. John Iafrate;Shota Tanaka

411
Citations
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

Daniele Bergamaschi;Yardena Samuels;Yardena Samuels;Yardena Samuels;Alexandra Sullivan;Marketa Zvelebil

335
Citations
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

Yochai Wolf;Osnat Bartok;Sushant Patkar;Gitit Bar Eli

330
Citations
ASPP1 and ASPP2: Common Activators of p53 Family Members

Daniele Bergamaschi;Yardena Samuels;Boquan Jin;Sai Duraisingham

320
Citations
Analysis of the genome to personalize therapy for melanoma

M A Davies;Y Samuels

302
Citations

Frequent Co-Authors

Steven A. Rosenberg National Institutes of Health

Victor E. Velculescu Johns Hopkins University School of Medicine

Bert Vogelstein Johns Hopkins University

Arie Admon Technion – Israel Institute of Technology

Nicholas K. Hayward QIMR Berghofer Medical Research Institute

Abdel G. Elkahloun National Human Genome Research Institute

Richard A. Scolyer Royal Prince Alfred Hospital

Michael A. Davies The University of Texas MD Anderson Cancer Center

Kenneth W. Kinzler Johns Hopkins University

Eytan Ruppin National Institutes of Health

External Links

Personal website of Yardena Samuels

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Genetics is a diverse field with many educational routes available. Beyond traditional degree paths, online programs have expanded access to related specialties for students seeking flexibility or accelerated learning opportunities.

Many healthcare professionals pursue further qualifications through programs such as rn to bsn without clinicals, which are designed for registered nurses aiming to obtain a bachelor's degree without on-site clinical requirements. For those already holding an MSN, a 1 year msn to dnp program online offers a rapid route to a terminal nursing practice degree.

For entry-level positions, there are options like medical assistant programs accelerated, which prepare students for clinical support roles in just a few weeks. If you are searching for less intensive or more accessible advanced degrees, exploring the easiest dnp programs can be a practical next step.

These pathways can complement a background in genetics, expanding your options in healthcare, research, and laboratory work. Online degree programs are helping shape the next generation of professionals across related fields.